» Articles » PMID: 20034100

Extending the Phenotype of Monosomy 1p36 Syndrome and Mapping of a Critical Region for Obesity and Hyperphagia

Overview
Specialty Genetics
Date 2009 Dec 25
PMID 20034100
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Rearrangements of 1p36 are the most frequently detected abnormalities in diagnostic testing for chromosomal cryptic imbalances and include variably sized simple terminal deletions, derivative chromosomes, interstitial deletions, and complex rearrangements. These rearrangements result in the specific pattern of malformation and neurodevelopmental disabilities that characterizes monosomy 1p36 syndrome. Thus far, no individual gene within this region has been conclusively determined to be causative of any component of the phenotype. Nor is it known if the rearrangements convey phenotypes via a haploinsufficiency mechanism or through a position effect. We have used multiplex ligation-dependent probe amplification to screen for deletions of 1p36 in a group of 154 hyperphagic and overweight/obese, PWS negative individuals, and in a separate group of 83 patients initially sent to investigate a variety of other conditions. The strategy allowed the identification and delineation of rearrangements in nine subjects with a wide spectrum of clinical presentations. Our work reinforces the association of monosomy 1p36 and obesity and hyperphagia, and further suggests that these features may be associated with non-classical manifestations of this disorder in addition to a submicroscopic deletion of approximately 2-3 Mb in size. Multiplex ligation probe amplification using the monosomy 1p36 syndrome-specific kit coupled to the subtelomeric kit is an effective approach to identify and delineate rearrangements at 1p36.

Citing Articles

SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females.

Radio F, Pang K, Ciolfi A, Levy M, Hernandez-Garcia A, Pedace L Am J Hum Genet. 2021; 108(3):502-516.

PMID: 33596411 PMC: 8008487. DOI: 10.1016/j.ajhg.2021.01.015.


CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression.

Tan S, Little H, Sarver D, Watkins P, Wong G FEBS Lett. 2020; 594(19):3227-3239.

PMID: 32749667 PMC: 7722243. DOI: 10.1002/1873-3468.13895.


Emerging roles for human glycolipid transfer protein superfamily members in the regulation of autophagy, inflammation, and cell death.

Mishra S, Gao Y, Zou X, Stephenson D, Malinina L, Hinchcliffe E Prog Lipid Res. 2020; 78:101031.

PMID: 32339554 PMC: 8350976. DOI: 10.1016/j.plipres.2020.101031.


Partial deficiency of CTRP12 alters hepatic lipid metabolism.

Tan S, Little H, Lei X, Li S, Rodriguez S, Wong G Physiol Genomics. 2016; 48(12):936-949.

PMID: 27815536 PMC: 5206390. DOI: 10.1152/physiolgenomics.00111.2016.


Identification of 1p36 deletion syndrome in patients with facial dysmorphism and developmental delay.

Seo G, Kim J, Cho J, Kim G, Seo E, Lee B Korean J Pediatr. 2016; 59(1):16-23.

PMID: 26893599 PMC: 4753195. DOI: 10.3345/kjp.2016.59.1.16.